ClinicalTrials.gg
RecruitingNCT06405620BUDDY-GUARDUpdated Sep 21, 2026

Use of a Social Assistance Robot in a Population of Children Subjected to Prolonged Isolation

An interventional study of Assistance robot in Social Isolation, sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 7 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Not applicable
Ages
7 Years to 18 Years
Sex
All
01

Study summary

During the period of isolation of the hospitalized child, contacts between the child and his family are impaired. Being away from home as well as from the social and family circle can be harmful for the hospitalized child. It seems necessary to measure the impact of the use of such an assistance robot both on the user himself and his family. Thus, it seems relevant to scientifically validate the benefit of using such an assistance robot to break iatrogenic social isolation and to measure the impact of this use.

02

Conditions studied

  • Social Isolation

Browse trials for

03

In context

Social Isolation

236 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's planned enrollment of 33 is below the median of 80 across 198 interventional studies indexed under Social Isolation.

Browse Social Isolation studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 807 studies on the registry; 209 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children hospitalized in the pediatric hemato-oncology department whose duration of isolation is estimated to be greater than two weeks.
  • Children who have accepted the robot and whose parents have accepted its use in their home.
  • Agreement of holders of parental authority for the inclusion of the hospitalized child.

Exclusion criteria

Exclusion Criteria:

  • Patient or two parents who do not have a sufficient level of French for research.
  • Cognitive or motor disorders in children, not allowing the use of the robot and/or the carrying out of semi-structured interviews.
  • Cognitive disorders in parents and/or siblings that do not allow semi-structured interviews to be carried out.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
33 participants (estimated)

Study arms

  • Experimental
    Robot intervention

    the child uses the assistance robot

    Other: Assistance robot

Interventions

  • OtherAssistance robot

    the child controls the robot at his parent's home from his room

06

What researchers measure

Primary outcomes

  1. Evaluate the use of a social assistance robot with children hospitalized in the hemato-oncology department and subjected to prolonged isolation

    number of activations of the robot and duration of the activations

    Time frame: 1 month

Secondary outcomes

  1. Psychological impact of the use of a social assistance robot on the child, his parents and his siblings

    psychological effects measured by semi-directive interviews of the parents and the brothers and sisters

    Time frame: Visit 1 between Day 10 and Day 20 et visit 2 between Day 21 and Day 45

  2. Psychological effect of the use of a social assistance robot on the practice of nursing professionals in the service

    The effects will be explored through semi-structured interviews of nursing professionnals.

    Time frame: Visit 2 between Day 21 and Day 45

07

Study locations

1 of 1 sites recruiting
  • Children University Hospital of Toulouse
    Toulouse, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06405620
Responsible party
Sponsor
First posted
May 8, 2024
Start date
Jun 1, 2024
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Nadege ALGANS
Contact
algans.n@chu-toulouse.fr
0561777204
Rémi IZOULET
principal investigator · Toulouse Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion